Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01NWS
|
|||
| Former ID |
DNC013515
|
|||
| Drug Name |
3-(biphenyl-4-yl)-1-(oxazol-2-yl)propan-1-one
|
|||
| Synonyms |
CHEMBL261172
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H15NO2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C2=CC=C(C=C2)CCC(=O)C3=NC=CO3
|
|||
| InChI |
1S/C18H15NO2/c20-17(18-19-12-13-21-18)11-8-14-6-9-16(10-7-14)15-4-2-1-3-5-15/h1-7,9-10,12-13H,8,11H2
|
|||
| InChIKey |
RKXYRLSZCAAEPX-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Feb 28;51(4):937-47. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.